Overexpression of a secretory leukocyte protease inhibitor in human gastric cancer

No abstract is available for this paper.

• Publication year

  2008

• Venue

  International Journal of Cancer

• Publication date

  2008-10-15

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1002/ijc.23746PMID 18688858
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Global cancer statistics

  2011cited by this paper
• Gene expression analysis of early and advanced gastric cancers

  2007cited by this paper
• Molecular biology of gastric cancer

  2007cited by this paper
• The secretory leukocyte protease inhibitor (SLPI) suppresses cancer cell invasion but promotes blood‐borne metastasis via an invasion‐independent pathway

  2007cited by this paper
• Direct regulation of androgen receptor-associated protein 70 by thyroid hormone and its receptors.

  2007cited by this paper
• Inhibitory effect of endothelin A receptor blockade on tumor growth and liver metastasis of a human gastric cancer cell line

  2007cited by this paper
• The secretory leukocyte protease inhibitor is a type 1 insulin-like growth factor receptor-regulated protein that protects against liver metastasis by attenuating the host proinflammatory response.

  2006cited by this paper
• Indirect regulation of human dehydroepiandrosterone sulfotransferase family 1A member 2 by thyroid hormones.

  2006cited by this paper
• Helicobacter pylori-induced downregulation of the secretory leukocyte protease inhibitor (SLPI) in gastric epithelial cell lines and its functional relevance for H. pylori-mediated diseases

  2006cited by this paper
• Identification of differential gene expression between intestinal and diffuse gastric cancer using cDNA microarray.

  2006cited by this paper
• Molecular mechanism of stomach carcinogenesis

  2005cited by this paper
• Identification of metastasis-associated genes in prostate cancer by genetic profiling of human prostate cancer cell lines.

  2005cited by this paper
• Use of serum secretory leukocyte protease inhibitor levels in patients to improve specificity of ovarian cancer diagnosis.

  2005cited by this paper
• Global Cancer Statistics, 2002

  2005cited by this paper
• Gene expression profiles in human gastric cancer: expression of maspin correlates with lymph node metastasis

  2005cited by this paper
• Gastric Adenocarcinoma: Review and Considerations for Future Directions

  2005cited by this paper
• Analysis of gastric cancer with cDNA microarray

  2004cited by this paper
• Molecular Classifiers for Gastric Cancer and Nonmalignant Diseases of the Gastric Mucosa

  2004cited by this paper
• Molecular biology of gastric cancer

  2004cited by this paper
• cDNA microarray analysis of invasive and tumorigenic phenotypes in a breast cancer model

  2004cited by this paper
• Secretory Leukocyte Protease Inhibitor in Cancer Development

  2004cited by this paper
• Overexpression of SPARC gene in human gastric carcinoma and its clinic–pathologic significance

  2004cited by this paper
• From Mice to Humans

  2004cited by this paper
• Expression of human kallikrein 7 (hK7/SCCE) and its inhibitor antileukoprotease (ALP/SLPI) in uterine endocervical glands and in cervical adenocarcinomas.

  2004cited by this paper
• Secretory leukocyte protease inhibitor promotes the tumorigenic and metastatic potential of cancer cells

  2003cited by this paper
• Cancer. Developing molecular biomarkers for cancer.

  2003cited by this paper
• Clinical application of cDNA microarrays in oncology.

  2003cited by this paper
• Genetic classification of intestinal-type and diffuse-type gastric cancers based on chromosomal loss and microsatellite instability

  2003cited by this paper
• Developing Molecular Biomarkers for Cancer

  2003cited by this paper
• Activation of Antimetastatic Nm23-H1 Gene Expression by Estrogen and Its α-Receptor.

  2002cited by this paper
• Resectable gastric cancer: operative mortality and survival analysis.

  2002cited by this paper
• Genome-wide analysis of gene expression in intestinal-type gastric cancers using a complementary DNA microarray representing 23,040 genes.

  2002cited by this paper
• Global gene expression analysis of gastric cancer by oligonucleotide microarrays.

  2002cited by this paper
• Activation of antimetastatic Nm23-H1 gene expression by estrogen and its alpha-receptor.

  2002cited by this paper
• Phospholipase A2 group IIA expression in gastric adenocarcinoma is associated with prolonged survival and less frequent metastasis

  2002cited by this paper
• Prognostic score of gastric cancer determined by cDNA microarray.

  2002cited by this paper
• Secretory Leukocyte Protease Inhibitor Mediates Proliferation of Human Endometrial Epithelial Cells by Positive and Negative Regulation of Growth-associated Genes*

  2002cited by this paper
• Molecular diagnosis of gastric cancer: present and future

  2001cited by this paper
• Coordinately up-regulated genes in ovarian cancer.

  2001cited by this paper
• Cathepsin B, L, and S Cleave and Inactivate Secretory Leucoprotease Inhibitor*

  2001cited by this paper
• Secretory leukocyte protease inhibitor mediates non-redundant functions necessary for normal wound healing

  2000cited by this paper
• Increased secretory leukoprotease inhibitor in patients with nonsmall cell lung carcinoma

  2000cited by this paper
• Prognostic Significance of CEA, CA 19-9 and CA 72-4 Preoperative Serum Levels in Gastric Carcinoma

  1999cited by this paper
• Japanese Classification of Gastric Carcinoma – 2nd English Edition –

  1998cited by this paper
• TNM Classification of Malignant Tumors

  1998cited by this paper
• Prognostic factors in gastric cancer

  1997cited by this paper
• Secretory leukocyte protease inhibitor suppresses the production of monocyte prostaglandin H synthase-2, prostaglandin E2, and matrix metalloproteinases.

  1997cited by this paper
• TNM classification of malignant tumors, fifth edition (1997)

  1997cited by this paper
• Japanese classification of gastric carcinoma

  1995cited by this paper
• Demonstration of skin‐derived antileukoproteinase (skalp) and its target enzyme human leukocyte elastase in squamous cell carcinoma

  1994cited by this paper
• Histogenesis of intestinal and diffuse types of gastric carcinoma.

  1991cited by this paper
• [Prognostic factors in gastric cancer].

  1988cited by this paper
• TNM Classification of Malignant Tumours

  1987cited by this paper
• Use of avidin-biotin-peroxidase complex (ABC) in immunoperoxidase techniques: a comparison between ABC and unlabeled antibody (PAP) procedures.

  1981cited by this paper
• A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding.

  1976cited by this paper

• ETV4 and ETV1-mediated downregulation of the secretory leukocyte protease inhibitor contributes to the indolent phenotype of early-stage prostate cancer.

  2025cites this paper
• Secretory leukocyte protease inhibitor as a novel predictive biomarker in patients with diabetic kidney disease

  2024cites this paper
• Role of Antimicrobial Peptides as Potential Arsenal Against SARS-CoV-2 and Other Pathogens

  2024cites this paper
• Secretory leukocyte protease inhibitor (SLPI) in cancer pathophysiology: Mechanisms of action and clinical implications.

  2023cites this paper
• Up‐regulation of secretory leukocyte protease inhibitor in human samples might have a potential role of predicting prostate cancer recurrence and progression after surgery and hormonal therapy

  2022cites this paper
• Differences in PD-L1 Expression between oral and oropharyngeal squamous cell carcinoma

  2022cites this paper
• High expression of secretory leukocyte protease inhibitor (SLPI) in stage III micro-satellite stable colorectal cancer is associated with reduced disease recurrence

  2022cites this paper
• Secretory Leukocyte Protease Inhibitor (SLPI) in mucosal tissues: Protects against inflammation, but promotes cancer.

  2021cites this paper
• Targeting secretory leukocyte protease inhibitor (SLPI) inhibits colorectal cancer cell growth, migration and invasion via downregulation of AKT

  2020cites this paper
• LCN2 Mediated by IL-17 Affects the Proliferation, Migration, Invasion and Cell Cycle of Gastric Cancer Cells by Targeting SLPI

  2020cites this paper
• CMAR_A_278902 12841..12849

  2020cites this paper
• Expression of the immune modulator secretory leukocyte protease inhibitor (SLPI) in colorectal cancer liver metastases and matched primary tumors is associated with a poorer prognosis

  2020cites this paper
• microRNA‐539 functions as a tumor suppressor in papillary thyroid carcinoma via the transforming growth factor β1/Smads signaling pathway by targeting secretory leukocyte protease inhibitor

  2019cites this paper
• Secretory leukocyte peptidase inhibitor expression and apoptosis effect in oral leukoplakia and oral squamous cell carcinoma.

  2018cites this paper
• SLPI (secretory leukocyte peptidase inhibitor)

  2017cites this paper
• Elevated Concentrations of SERPINE2/Protease Nexin-1 and Secretory Leukocyte Protease Inhibitor in the Serum of Patients with Papillary Thyroid Cancer

  2017cites this paper
• SLPI promotes the gastric cancer growth and metastasis by regulating the expression of P53, Bcl-2 and Caspase-8.

  2017cites this paper
• Secretory leukocyte protease inhibitor (SLPI) as a potential target for inhibiting metastasis of triple-negative breast cancers

  2017cites this paper
• Human uterus myoma and gene expression profiling: A novel in vitro model for studying secretory leukocyte protease inhibitor-mediated tumor invasion.

  2016cites this paper
• CXCL1 gene silencing inhibits HGC803 cell migration and invasion and acts as an independent prognostic factor for poor survival in gastric cancer

  2016cites this paper
• Secretory leukocyte protease inhibitor is a survival and proliferation factor for castration-resistant prostate cancer

  2016cites this paper
• SLPI knockdown induced pancreatic ductal adenocarcinoma cells proliferation and invasion

  2015cites this paper
• Nodal metastasis and survival in oral cancer: Association with protein expression of SLPI, not with LCN2, TACSTD2, or THBS2

  2015cites this paper
• Human Cancer Biology Interleukin-32 IncreasesHumanGastric Cancer Cell Invasion Associated with Tumor Progression and Metastasis

  2014cites this paper
• Overexpression of NUAK1 is associated with disease-free survival and overall survival in patients with gastric cancer

  2014cites this paper
• Interleukin-32 Increases Human Gastric Cancer Cell Invasion Associated with Tumor Progression and Metastasis

  2014cites this paper
• Human Antimicrobial Peptides and Proteins

  2014cites this paper
• Gene expression analyses on skin lesions from patients with familial adenomatous polyposis

  2014cites this paper
• Interleukin-32IncreasesHumanGastricCancerCellInvasion Associated with Tumor Progression and Metastasis

  2014cites this paper
• Protein chimerism: Novel source of protein diversity in humans adds complexity to bottom‐up proteomics

  2013cites this paper
• A 256 Pixel Magnetoresistive Biosensor Microarray in 0.18 µm CMOS

  2013influential citation
• Anti‐tumor effect of SLPI on mammary but not colon tumor growth

  2013cites this paper
• WAPing Out Pathogens and Disease in the Mucosa: Roles for SLPI and Trappin-2

  2013cites this paper
• Glyoxalase-I Is a Novel Prognosis Factor Associated with Gastric Cancer Progression

  2012cites this paper
• The relationship between secretory leukocyte protease inhibitor expression and Epstein-Barr virus status among patients with nasopharyngeal carcinoma.

  2012cites this paper
• Fish Oil Alters Tamoxifen-Modulated Expression of mRNAs That Encode Genes Related to Differentiation, Proliferation, Metastasis, and Immune Response in Rat Mammary Tumors

  2012cites this paper
• Overexpression of ADP‐ribosylation factor 1 in human gastric carcinoma and its clinicopathological significance

  2012cites this paper
• Human urine proteomics: building a list of human urine cancer biomarkers

  2011cites this paper
• Immunotherapy with SLPI over-expressing mammary tumor cells decreases tumor growth

  2011cites this paper
• Mucosal Progranulin expression is induced by H. pylori, but independent of Secretory Leukocyte Protease Inhibitor (SLPI) expression

  2011cites this paper
• Clobetasol down-regulates SLPI expression in U937 monocytoid cells.

  2011cites this paper
• Secretory leukocyte protease inhibitor is associated with MMP-2 and MMP-9 to promote migration and invasion in SNU638 gastric cancer cells.

  2011cites this paper
• Latexin expression is downregulated in human gastric carcinomas and exhibits tumor suppressor potential

  2011cites this paper
• Overexpression of gelsolin in human cervical carcinoma and its clinicopathological significance.

  2011cites this paper
• Glucose‐regulated protein 58 modulates cell invasiveness and serves as a prognostic marker for cervical cancer

  2011cites this paper
• Overexpression of CXCL1 and its receptor CXCR2 promote tumor invasion in gastric cancer.

  2011cites this paper
• PROTEASE INHIBITORS AS ANTICANCER AGENTS

  2010cites this paper
• Metabolomic investigation of gastric cancer tissue using gas chromatography/mass spectrometry

  2010cites this paper
• Identification of novel hub genes associated with liver metastasis of gastric cancer

  2009cites this paper